EH
XBI icon

Equitable Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Equitable Holdings’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.95M Buy
24,151
+2,132
+10% +$266K 0.02% 606
2025
Q4 		$2.68M Buy
22,019
+3,992
+22% +$458K 0.02% 544
2025
Q3 		$1.81M Sell
18,027
-4,672
-21% -$421K 0.01% 654
2025
Q2 		$1.88M Sell
22,699
-700
-3% -$55.8K 0.02% 592
2025
Q1 		$1.9M Buy
23,399
+30
+0.1% +$2.68K 0.02% 524
2024
Q4 		$2.1M Buy
23,369
+1,215
+5% +$118K 0.02% 472
2024
Q3 		$2.19M Sell
22,154
-6,947
-24% -$683K 0.02% 467
2024
Q2 		$2.7M Buy
29,101
+4,819
+20% +$432K 0.03% 390
2024
Q1 		$2.3M Buy
24,282
+4,573
+23% +$424K 0.03% 411
2023
Q4 		$1.76M Sell
19,709
-10,152
-34% -$754K 0.02% 445
2023
Q3 		$2.18M Sell
29,861
-964
-3% -$77K 0.03% 342
2023
Q2 		$2.56M Sell
30,825
-3,961
-11% -$331K 0.04% 296
2023
Q1 		$2.65M Sell
34,786
-3,783
-10% -$314K 0.04% 276
2022
Q4 		$3.2M Buy
38,569
+7,758
+25% +$628K 0.06% 228
2022
Q3 		$2.44M Buy
30,811
+3,108
+11% +$262K 0.05% 230
2022
Q2 		$2.06M Buy
27,703
+7,523
+37% +$565K 0.04% 262
2022
Q1 		$1.81M Buy
20,180
+875
+5% +$80.8K 0.03% 300
2021
Q4 		$2.16M Sell
19,305
-7,753
-29% -$935K 0.03% 267
2021
Q3 		$3.4M Buy
27,058
+2,920
+12% +$376K 0.06% 195
2021
Q2 		$3.27M Buy
24,138
+1,549
+7% +$204K 0.06% 190
2021
Q1 		$3.06M Sell
22,589
-18,733
-45% -$2.8M 0.06% 179
2020
Q4 		$5.82M Sell
41,322
-1,333
-3% -$171K 0.13% 113
2020
Q3 		$4.75M Buy
42,655
+3,154
+8% +$354K 0.12% 115
2020
Q2 		$4.42M Buy
39,501
+3,599
+10% +$354K 0.13% 114
2020
Q1 		$2.78M Buy
35,902
+30,996
+632% +$2.74M 0.1% 130
2019
Q4 		$467K Buy
+4,906
New +$424K 0.01% 414

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Equitable Holdings's XBI Position: Q1 2026 in Review

Equitable Holdings increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.7% in Q1 2026, buying an estimated $266K and bringing the position to 24,151 shares worth $2.95M. The position accounts for 0.02% of the portfolio, ranked #606.

Equitable Holdings first reported a position in XBI in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.82M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Equitable Holdings held 24,151 shares of State Street SPDR S&P Biotech ETF worth $2.95M as of Q1 2026.
  • Equitable Holdings bought 2,132 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $266K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Equitable Holdings's portfolio in Q1 2026, its #606 holding.
  • Equitable Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 26 quarters since.
  • Equitable Holdings's State Street SPDR S&P Biotech ETF position peaked at $5.82M in Q4 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.